Clomiphene citrate, a selective estrogen receptor modulator widely used for ovulation induction, has been rarely associated with severe hypertriglyceridemia, representing an under-recognized but potentially serious adverse effect. The gene discussed is ESR1; the disease is hypertriglyceridemia.